ArticleCancer research2012

KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer.

Jonathan A Kelber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.